Human CTLA-4 antibodies and their uses
Details for Australian Patent Application No. 2006201520 (hide)
International Classifications
Event Publications
27 April 2006 Complete Application Filed
11 May 2006 Application Open to Public Inspection
Published as AU-B-2006201520
19 March 2009 Application Accepted
Published as AU-B-2006201520
16 July 2009 Standard Patent Sealed
19 January 2012 Extension of Term of Standard Patents
Medarex, Inc. The earliest first regulatory approval date provided by the patentee 04 Jul 2011 For the goods YERVOY ipilimumab; WINGLORE ipilimumab Address for service in Australia: Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
7 June 2012 Extension granted
Medarex, Inc. The earliest first regulatory approval date provided by the patentee 04 Jul 2011 For the goods YERVOY ipilimumab; WINGLORE ipilimumab Extension of Term of patent pursuant to Section 77 expires on 24 Aug 2025
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006201521-Surgical fastener with predetermined resorption rate
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser